REFERENCES
- Lindquist P, Fujikawa K, Davie E. Activation of bovine factor IX (Christmas factor) by factor XIa (activated plasma thromboplastin antecedent) and a protease from Russel's viper venom. J Biol Chem 1978; 253: 1902–9.
- Davie E, Fujikawa K, Kisiel W. The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 1991; 30: 10363–70.
- Brandsetter H, Bauer M, Huber R, Lollar P, Bode W. X-ray structure of clotting factor IXa: active site module structure related to Xase activity and hemophilia Proc Natl Acad Sci USA 1995; 92: 9796–800.
- Rao Z, Handford P, Mayhew M, Knott V, Brownlee GG, Stuart D. The structure of a Ca2+ -binding epidermal growth factor-like domain: its role in protein-protein interactions. Cell 1995; 82: 131–41.
- Christophe OD, Lenting PJ, Kolkman JA, Brownlee GG, Mertens K. Blood coagulation factor IX residues G1u78 and Arg 94 provide a link between both epidermal growth factor-like domains that is crucial in the interaction with factor VIII light chain. J Biol Chem 1998; 273: 222–7.
- Celie PHN, Lenting PJ, Mertens K. Hydrophobic contact between the two epidermal growth factor-like domains of blood coagulation factor IX contributes to enzymatic activity. J Biol Chem 2000; 275: 229–34.
- Zhong D, Smith KJ, Birktoft JJ, Bajaj SP. First epidermal growth factor-like domain of human blood coagulation factor IX is required for its activation by factor Vila/tissue factor but not by factor XIa. Proc Natl Acad Sci USA 1994; 91: 3574–8.
- Lozier JN, Monroe DM, Stanfield-Oakley S, Lin S, Smith KJ, Roberts HR, High KA. Factor IX New London: Substitution of proline for glutamine at position 50 causes severe hemophilia B. Blood 1990; 75: 1097–104.
- Lenting PJ, Christophe OD, ter Maat H, Rees JG, Mertens K. Ca2+ binding to the first epidermal growth factor-like domain of human blood coagulation factor IX promotes enzyme activity and factor VIII light chain binding. J Biol Chem 1996; 271: 25332–37.
- Persson KEM, Knobe KE, Stenflo J. An anti-EGF monoclonal antibody that detects intramolecular communication in factor IX. BBRC 2001; 286: 1039–44.
- Persson KEM, Villoutreix BO, Thämlitz A-M, Knobe KE, Stenflo J. The N-terminal EGF domain of coagulation factor IX: Probing its functions in the activation of factor IX and factor X with a monoclonal antibody. J Biol Chem 2002; 277: 35616–24.
- Hamaguchi N, Stafford D. In vitro mutagenesis study of two critical glutamic acids in the calcium binding loop of the factor IX heavy chain. Thromb Haemost 1994; 72: 856–61.
- Bajaj S, Schmidt A, Mathur A, Padmanabhan K, Zhong D, Mastri M, Fay P. Factor IXa:factor Villa interaction. helix 330-338 of factor IXa interacts with residues 558-565 and spatially adjacent regions of the a2 subunit of factor J Biol Chem 2001; 276: 16302–9.
- Fay PJ, Beattie T, Huggins CF, Regan LM. Factor VIIIa A2 subunit residues 558-565 represent a factor IXa interactive site. J Biol Chem 1994; 269: 20522–7.
- Lenting P, van de Loo J, Donath M, van Mourik J, Mertens K. The sequence Glu1811-Lys1818 of human blood coagulation factor VIII comprises a binding site for activated factor IX. J Biol Chem 1996; 271: 1935–40.